Furthermore, we investigated the molecular pathway of Peroxiredoxin-I (Prx-I), one of the identified down-regulated proteins in bladder cancer identified by iTRAQ after treatment with BI-TK/GCV. This evidence concerns the gene PRDX1 and urinary bladder carcinoma.